$3.22
-0.005-0.16%
In chiusura: Nov 19, 4:00 PM EST
$3.40
0.185.59%
Post-mercato: 5:13 PM EST

Larimar Therapeutics (LRMR) earnings history, EPS estimates, revenue forecasts and company guidance.
Earnings Per Share (Non-GAAP)
| Trimestre fiscale | Data segnalata | EPS effettivo | EPS stimato | Sorpresa% |
|---|---|---|---|---|
| Q3 | Nov 16, 2026 | $-0.29 | $-0.36 | 19.4 % |
| Q2 | Aug 4, 2026 | $-0.30 | $-0.38 | 21.1 % |
| Q1 | May 14, 2026 | $-0.31 | $-0.56 | 44.6 % |
| Q4 | Mar 19, 2026 | $-0.73 | $-0.50 | -46.0 % |
Quarterly Revenue (Billions)
| Metric | Q3 '26 | Q2 '26 | Q1 '26 | Q4 '25 |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Estimate | $-0.36 | $-0.38 | $-0.56 | $-0.50 |
| Actual | $-0.29 | $-0.30 | $-0.31 | $-0.73 |
| Surprise | +19.4% | +21.1% | +44.6% | -46.0% |
| Revenue | ||||
| Estimate | — | — | — | — |
| Actual | $0 | $0 | $0 | $0 |
| Surprise | — | — | — | — |
| Metric | Q4 '26E | Q1 '27E | Q2 '27E | Q3 '27E |
|---|---|---|---|---|
| Earnings Per Share (Non-GAAP) | ||||
| Consensus | $-0.34 | $-0.36 | $-0.35 | $-0.34 |
| Revenue | ||||
| Consensus | — | — | — | — |